TechStep: Technology-based Stepped Care to Stem Transgender Adolescent Risk Transmission
Completed · Not applicable
Conditions studied: HIV
In brief
TechStep is a three-arm, technology-based randomized controlled trial (RCT), with a stepped care approach, among high-risk HIV-negative transgender feminine, transgender masculine, and gender non-conforming youth and young adults for reducing sexual risk behaviors and increasing pre-exposure prophylaxis (PrEP) uptake. Participants are randomized into one of three conditions for a 6-month intervention: Group 1: culturally relevant theory-based text messages (Text+Step); or, Group 2: culturally relevant mobile-enhanced website (WebApp+Step); or, Group 3: informational website control condition with no theoretically based text messages or WebApp.
Key facts
- Study ID
- NCT04000724
- Run by
- Friends Research Institute, Inc.
- People needed
- 254
- Starts
- 2019-10-18
- Expected to finish
- 2022-05-31
- Last updated by the study team
- 2024-02-20
Who can join
Age: 15 and older, up to 24. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Report vaginal or anal sex (either insertive or receptive; excluding sex toys) with another person in the previous 12 months;
- Confirmed negative HIV test;
- Availability to meet with research staff in person or online at either the Baylor College of Medicine (BCM) Adolescent Medicine Trials Unit in Houston, Children's Hospital of Philadelphia, Children's Hospital Los Angeles, the PRIDE Health Research Consortium in New York City, or the Fenway Institute in Boston
- Have a mobile device with short messaging service (SMS; i.e. "texting") and Internet access capabilities; and
- Read and speak English (since the intervention is built in English)
You may not qualify if…
- Does not report vaginal or anal sex (either insertive or receptive; excluding sex toys) with another person in the previous 12 months;
- Reactive or indeterminate HIV test;
- Unable to meet with research staff in person or online at either the Baylor College of Medicine (BCM) Adolescent Medicine Trials Unit in Houston, Children's Hospital of Philadelphia, Children's Hospital Los Angeles, the PRIDE Health Research Consortium in New York City, or the Fenway Institute in Boston
- Does not have a mobile device with SMS and Internet access capabilities;
- Unable to read and speak English (since the intervention is built and delivered in English)
- Unwilling or unable to comply with protocol requirements;
- Unable to understand the Informed Consent/Assent Form.
Where it is running
- Children's Hospital Los Angeles — Los Angeles, California, United States
- The Fenway Institute — Boston, Massachusetts, United States
- PRIDE Health Research Consortium at Hunter CUNY — New York, New York, United States
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
- Baylor College of Medicine — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.